drugset / Trial / NCT00106691

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

NCT00106691

Phase 3 Completed 1589 enrolled GTx
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic intraepithelial neoplasia (PIN).

Timeline

Start
2005-01
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Toremifene Small molecule 20 mg Oral